 | • レポートコード：QYR9ST02544 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の精神疾患薬市場について調査・分析し、以下の構成でお届け致します。精神疾患薬の種類別には、抗精神病薬、抗うつ薬、抗不安薬（抗不安薬）、抗癲癇薬、興奮剤、認知障害及び認知症、睡眠障害治療、薬物乱用治療に、用途別には、病院、診療所、ドラッグストアに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別精神疾患薬売上データ ・地域別精神疾患薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別精神疾患薬市場規模：抗精神病薬、抗うつ薬、抗不安薬（抗不安薬）、抗癲癇薬、興奮剤、認知障害及び認知症、睡眠障害治療、薬物乱用治療 ・用途別精神疾患薬市場規模：病院、診療所、ドラッグストア ・主要メーカーの企業情報：Johnson and Johnson、Pfizer、Eli Lilly、GlaxoSmithKline、AstraZeneca、Bristol-Myers Squibb ・精神疾患薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.The global Mental Illness Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mental Illness Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Mental Illness Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Mental Illness Drugs in these regions.
This research report categorizes the global Mental Illness Drugs market by top players/brands, region, type and end user. This report also studies the global Mental Illness Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Market size by Product
Antipsychotics
Antidepressants
Antianxiety (anxiolyitcs)
Anti-seizure medications
Stimulants
Cognitive disorders and dementia
Sleep disorder treatments
Substance abuse treatments
Market size by End User
Hospital
Clinic
Drugstore
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Mental Illness Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Mental Illness Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Mental Illness Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Mental Illness Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Mental Illness Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mental Illness Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Mental Illness Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Mental Illness Drugs Market Size Growth Rate by Product
1.4.2 Antipsychotics
1.4.3 Antidepressants
1.4.4 Antianxiety (anxiolyitcs)
1.4.5 Anti-seizure medications
1.4.6 Stimulants
1.4.7 Cognitive disorders and dementia
1.4.8 Sleep disorder treatments
1.4.9 Substance abuse treatments
1.5 Market by End User
1.5.1 Global Mental Illness Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drugstore
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Mental Illness Drugs Market Size
2.1.1 Global Mental Illness Drugs Revenue 2014-2025
2.1.2 Global Mental Illness Drugs Sales 2014-2025
2.2 Mental Illness Drugs Growth Rate by Regions
2.2.1 Global Mental Illness Drugs Sales by Regions
2.2.2 Global Mental Illness Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Mental Illness Drugs Sales by Manufacturers
3.1.1 Mental Illness Drugs Sales by Manufacturers
3.1.2 Mental Illness Drugs Sales Market Share by Manufacturers
3.1.3 Global Mental Illness Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Mental Illness Drugs Revenue by Manufacturers
3.2.1 Mental Illness Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Mental Illness Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Mental Illness Drugs Price by Manufacturers
3.4 Mental Illness Drugs Manufacturing Base Distribution, Product Types
3.4.1 Mental Illness Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mental Illness Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Mental Illness Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Mental Illness Drugs Sales by Product
4.2 Global Mental Illness Drugs Revenue by Product
4.3 Mental Illness Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Mental Illness Drugs Breakdown Data by End User
6 North America
6.1 North America Mental Illness Drugs by Countries
6.1.1 North America Mental Illness Drugs Sales by Countries
6.1.2 North America Mental Illness Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Mental Illness Drugs by Product
6.3 North America Mental Illness Drugs by End User
7 Europe
7.1 Europe Mental Illness Drugs by Countries
7.1.1 Europe Mental Illness Drugs Sales by Countries
7.1.2 Europe Mental Illness Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mental Illness Drugs by Product
7.3 Europe Mental Illness Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Mental Illness Drugs by Countries
8.1.1 Asia Pacific Mental Illness Drugs Sales by Countries
8.1.2 Asia Pacific Mental Illness Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Mental Illness Drugs by Product
8.3 Asia Pacific Mental Illness Drugs by End User
9 Central & South America
9.1 Central & South America Mental Illness Drugs by Countries
9.1.1 Central & South America Mental Illness Drugs Sales by Countries
9.1.2 Central & South America Mental Illness Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Mental Illness Drugs by Product
9.3 Central & South America Mental Illness Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Mental Illness Drugs by Countries
10.1.1 Middle East and Africa Mental Illness Drugs Sales by Countries
10.1.2 Middle East and Africa Mental Illness Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Mental Illness Drugs by Product
10.3 Middle East and Africa Mental Illness Drugs by End User
11 Company Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Company Business Overview
11.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Johnson and Johnson Mental Illness Drugs Products Offered
11.1.5 Johnson and Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Mental Illness Drugs Products Offered
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Company Business Overview
11.3.3 Eli Lilly Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Eli Lilly Mental Illness Drugs Products Offered
11.3.5 Eli Lilly Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline Mental Illness Drugs Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Mental Illness Drugs Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Company Business Overview
11.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Bristol-Myers Squibb Mental Illness Drugs Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
12 Future Forecast
12.1 Mental Illness Drugs Market Forecast by Regions
12.1.1 Global Mental Illness Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Mental Illness Drugs Revenue Forecast by Regions 2019-2025
12.2 Mental Illness Drugs Market Forecast by Product
12.2.1 Global Mental Illness Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Mental Illness Drugs Revenue Forecast by Product 2019-2025
12.3 Mental Illness Drugs Market Forecast by End User
12.4 North America Mental Illness Drugs Forecast
12.5 Europe Mental Illness Drugs Forecast
12.6 Asia Pacific Mental Illness Drugs Forecast
12.7 Central & South America Mental Illness Drugs Forecast
12.8 Middle East and Africa Mental Illness Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mental Illness Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Mental Illness Drugs Product Picture
Table Mental Illness Drugs Market Segments
Table Key Manufacturers Mental Illness Drugs Covered
Table Global Mental Illness Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Mental Illness Drugs Sales Market Share by Product 2014-2025
Figure Antipsychotics Product Picture
Table Major Manufacturers of Antipsychotics
Figure Antidepressants Product Picture
Table Major Manufacturers of Antidepressants
Figure Antianxiety (anxiolyitcs) Product Picture
Table Major Manufacturers of Antianxiety (anxiolyitcs)
Figure Anti-seizure medications Product Picture
Table Major Manufacturers of Anti-seizure medications
Figure Stimulants Product Picture
Table Major Manufacturers of Stimulants
Figure Cognitive disorders and dementia Product Picture
Table Major Manufacturers of Cognitive disorders and dementia
Figure Sleep disorder treatments Product Picture
Table Major Manufacturers of Sleep disorder treatments
Figure Substance abuse treatments Product Picture
Table Major Manufacturers of Substance abuse treatments
Table Global Mental Illness Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Hospital
Figure Clinic
Figure Drugstore
Figure Mental Illness Drugs Report Years Considered
Figure Global Mental Illness Drugs Market Size 2014-2025 (Million US$)
Figure Global Mental Illness Drugs Sales 2014-2025 (MT)
Table Global Mental Illness Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Mental Illness Drugs Sales by Regions 2014-2019 (MT)
Table Global Mental Illness Drugs Sales Market Share by Regions 2014-2019
Figure Global Mental Illness Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Mental Illness Drugs Sales Market Share by Regions
Table Global Mental Illness Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Mental Illness Drugs Revenue Market Share by Regions 2014-2019
Figure Global Mental Illness Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Mental Illness Drugs Revenue Market Share by Regions
Table Global Mental Illness Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Mental Illness Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Mental Illness Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Mental Illness Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Mental Illness Drugs Revenue Share by Manufacturers (2014-2019)
Figure Mental Illness Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Mental Illness Drugs Price (2014-2019) (USD/MT)
Table Mental Illness Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Mental Illness Drugs Product Type
Table Date of International Manufacturers Enter into Mental Illness Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table Global Mental Illness Drugs Sales Share by Product (2014-2019)
Figure Global Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure Global Mental Illness Drugs Sales Market Share by Product in 2018
Table Global Mental Illness Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Mental Illness Drugs Revenue Share by Product (2014-2019)
Figure Global Mental Illness Drugs Revenue Market Share by Product (2014-2019)
Figure Global Mental Illness Drugs Revenue Market Share by Product in 2018
Table Mental Illness Drugs Price by Product 2014-2019 (USD/MT)
Table Global Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table Global Mental Illness Drugs Sales Share by End User (2014-2019)
Figure Global Sales Mental Illness Drugs Market Share by End User (2014-2019)
Figure Global Sales Mental Illness Drugs Market Share by End User in 2018
Figure North America Mental Illness Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Mental Illness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Mental Illness Drugs Sales by Countries (2014-2019) (MT)
Table North America Mental Illness Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Mental Illness Drugs Sales Market Share by Countries
Table North America Mental Illness Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Mental Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Mental Illness Drugs Revenue Market Share by Countries
Figure United States Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Mental Illness Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table North America Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Mental Illness Drugs Market Share by Product
Table North America Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table North America Mental Illness Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Mental Illness Drugs Market Share by End User
Figure Europe Mental Illness Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Mental Illness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Mental Illness Drugs Sales by Countries (2014-2019) (MT)
Table Europe Mental Illness Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Mental Illness Drugs Sales Market Share by Countries
Table Europe Mental Illness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Mental Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Mental Illness Drugs Revenue Market Share by Countries
Figure Germany Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table Europe Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Mental Illness Drugs Market Share by Product
Table Europe Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table Europe Mental Illness Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Mental Illness Drugs Market Share by End User
Figure Asia Pacific Mental Illness Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Mental Illness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Mental Illness Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Mental Illness Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Mental Illness Drugs Sales Market Share by Countries
Table Asia Pacific Mental Illness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Mental Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Mental Illness Drugs Revenue Market Share by Countries
Figure China Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Mental Illness Drugs Market Share by Product
Table Asia Pacific Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Mental Illness Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Mental Illness Drugs Market Share by End User
Figure Central & South America Mental Illness Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Mental Illness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Mental Illness Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Mental Illness Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Mental Illness Drugs Sales Market Share by Countries
Table Central & South America Mental Illness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Mental Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Mental Illness Drugs Revenue Market Share by Countries
Figure Brazil Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Mental Illness Drugs Market Share by Product
Table Central & South America Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Mental Illness Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Mental Illness Drugs Market Share by End User
Figure Middle East and Africa Mental Illness Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Mental Illness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Mental Illness Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Mental Illness Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Mental Illness Drugs Sales Market Share by Countries
Table Middle East and Africa Mental Illness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Mental Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Mental Illness Drugs Revenue Market Share by Countries
Figure GCC Countries Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Mental Illness Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Mental Illness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Mental Illness Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Mental Illness Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Mental Illness Drugs Market Share by Product
Table Middle East and Africa Mental Illness Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Mental Illness Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Mental Illness Drugs Market Share by End User
Table Johnson and Johnson Company Details
Table Johnson and Johnson Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson and Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Mental Illness Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Mental Illness Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Mental Illness Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Mental Illness Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Mental Illness Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Mental Illness Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Mental Illness Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Mental Illness Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Mental Illness Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Mental Illness Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Mental Illness Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Mental Illness Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Mental Illness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Mental Illness Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Mental Illness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Mental Illness Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Mental Illness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Mental Illness Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Mental Illness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Mental Illness Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Mental Illness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Mental Illness Drugs Value Chain
Table Mental Illness Drugs Customers List
Table Mental Illness Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
発作治療の世界市場：市場規模・現状・予測 An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain.Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. In 2018, th…- 認知症薬の世界市場：インサイト・予測 The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product ty…
- 認知症および運動障害の治療の世界市場：市場規模・現状・予測 Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…
- 抗自殺薬の世界市場：インサイト・予測 Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for p…
- 世界の精神療法薬市場：専門的調査 A psychotherapeutics drug is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. The global Psychotherapeutics Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during…